FDA Enforcement Class II Terminated

Concerto User Interface Software provided with the following systems: (1) Xstrahl 100 Electronic Brachytherapy - 100kV Superficial X-Ray Therapy System; (2) Xstrahl 150 Electronic Brachytherapy - 150kV Superficial X-Ray Therapy System; (3) Xstrahl 200 - 225kV Superficial / Orthovoltage X-Ray Therapy System; (4) Xstrahl 300 - 300kV Orthovoltage X-Ray Therapy System; (5) Xstrahl X 80 Photoelectric Therapy System.

Recall: Z-0174-2022 · Reported November 3, 2021

Enforcement

Recall Number
Z-0174-2022
Event ID
88732
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Xstrahl Limited
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
November 3, 2021
Initiation Date
April 26, 2021
Classification Date
October 26, 2021
Termination Date
January 26, 2024
Address
Unit 2, Maybrook Industrial Estate Maybro; Maybrook Road, Walsall, N/A, N/A, United Kingdom

Description

Concerto User Interface Software provided with the following systems: (1) Xstrahl 100 Electronic Brachytherapy - 100kV Superficial X-Ray Therapy System; (2) Xstrahl 150 Electronic Brachytherapy - 150kV Superficial X-Ray Therapy System; (3) Xstrahl 200 - 225kV Superficial / Orthovoltage X-Ray Therapy System; (4) Xstrahl 300 - 300kV Orthovoltage X-Ray Therapy System; (5) Xstrahl X 80 Photoelectric Therapy System.

Reason

If a saved treatment plan with 2 opposing beams is edited prior to approval, then Beam 2 is not updated with the changed parameters upon selecting save, resulting in error messages during the treatment and possible mis-treatment.

Code Info

V2.0, V2.1, and V2.2 when 2 opposing beam treatment plans are used.

Distribution

Worldwide distribution - US Nationwide distribution in the states of AZ, CA, FL, KY, NV, OR, PA, TN, and TX. The countries of Austria, Germany, and Switzerland.

Quantity

25 systems in the U.S.